Chairman Howard Lutnick discloses Non-Hodgkin's Lymphoma diagnosis, expects full recovery in 4 months

NEWMARK GROUP, INC.

Howard Lutnick diagnosed with highly treatable Non-Hodgkin's Lymphoma; expects to be cancer-free in 4 months.
Treatment includes six chemotherapy sessions from Oct 18, 2021 through end of Jan 2022.
Lutnick plans to continue serving as Chairman during treatment period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.